FDA Approves Eplontersen (Wainua) for ATTRv Polyneuropathy
The FDA has approved eplontersen (Wainua) for treating polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis, making it the only medication approved for self-administration via auto-injector pen for this condition.
Source: hcplive.com